AMENDMENT #1 TO PATENT LICENSE AGREEMENTPatent License Agreement • August 20th, 2019 • TFF Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledAugust 20th, 2019 Company IndustryThis Amendment #1 to the Patent License Agreement (“Amendment”) is made and entered into as of November 30, 2018 (“Amendment Effective Date”) by and between TFF Pharmaceuticals, Inc. (“Licensee”) and The University of Texas at Austin, on behalf of the Board of Regents of the University of Texas System (“Licensor”), an agency of the State of Texas.
AMENDMENT #1 TO PATENT LICENSE AGREEMENTPatent License Agreement • July 17th, 2019 • TFF Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledJuly 17th, 2019 Company IndustryThis Amendment #1 to the Patent License Agreement (“Amendment”) is made and entered into as of November 30, 2018 (“Amendment Effective Date”) by and between TFF Pharmaceuticals, Inc. (“Licensee”) and The University of Texas at Austin, on behalf of the Board of Regents of the University of Texas System (“Licensor”), an agency of the State of Texas.